Form 4: Zenas BioPharma CEO Increases Stake with Recent Share Purchases

Zenas BioPharma's CEO, Leon O. Moulder Jr., has increased his holdings in the company through recent open market purchases of common stock.

Summary

• Leon O. Moulder Jr., CEO of Zenas BioPharma, has acquired additional shares of the company's common stock.
• On November 18, 2024, Mr. Moulder purchased 7,500 shares at a weighted average price of $15, with individual transactions ranging from $14.81 to $15.32.
• On November 19, 2024, he purchased another 2,500 shares at a weighted average price of $14.57, with individual transactions ranging from $14.50 to $14.62.
• Following these transactions, Mr. Moulder directly owns 171,155 shares of Zenas BioPharma common stock.
• Additionally, Mr. Moulder may be deemed to have sole voting and dispositive power over 1,672,039 shares held by Tellus BioVentures LLC, where he is the Managing Member.

Sentiment

Score: 7

Explanation: The document reflects a positive sentiment due to the CEO's increased investment in the company, suggesting confidence in its future. However, it is a routine filing and not a major event.

Positives

• The CEO's purchase of shares indicates confidence in the company's future prospects.
• The increased stake aligns the CEO's interests more closely with those of other shareholders.

Management Comments

• Mr. Moulder disclaims beneficial ownership of the shares held by Tellus BioVentures LLC except to the extent of his pecuniary interest therein.

Industry Context

Insider buying is often seen as a positive signal in the biotech industry, suggesting management's belief in the company's potential.

Comparison to Industry Standards

• Insider buying is a common practice, but the size and frequency of purchases can vary significantly across companies and industries.
• It is not uncommon for CEOs to purchase shares in their own companies, especially after a period of price weakness or in anticipation of positive developments.
• The purchases by Mr. Moulder are relatively small compared to the total outstanding shares, but they are still a notable signal.

Stakeholder Impact

• The increased stake by the CEO may positively influence shareholder confidence.
• The purchases may signal to employees that management is confident in the company's direction.

Key Dates

Keywords

Zenas BioPharma, Leon O. Moulder Jr., insider trading, share purchase, common stock, Tellus BioVentures